• linkedin
  • Increase Font
  • Sharebar

    Biologic use beyond psoriasis




    Most of the major advances in the targeted treatment of melanoma have been in biologic therapies, according to Dr. Heffernan.

    “One of the first biologic treatments developed [and approved] for melanoma ipilimumab injection (Yervoy, Bristol-Myers Squibb) is for the treatment of unresectable or metastatic melanoma. It upregulates the immune system to fuel the immune response to the cancer,” he said.

    READ: Technology advances melanoma diagnosis, treatment

    More to come

    Dr. Heffernan said he anticipates that, by 2025, there will be several biologic agents approved for the targeted treatment of specific skin diseases.

    “As the familiarity with biologics has grown and the comfort with their safety profile has grown, dermatologists and other investigators have felt more and more comfortable studying biologics in some less common but still severe diseases,” he said. “That’s really gratifying because sometimes the use of these medications has taught us about the diseases, and has shown that sometimes there are safe and hopefully effective ways to treat people who suffer from these life-altering diseases.”

    NEXT: References

    Lisette Hilton
    Lisette Hilton is president of Words Come Alive, based in Boca Raton, Florida.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Latest Tweets Follow